Effect of Equivalent Doses of Fentanyl, Sufentanil, and Remifentanil on the Incidence and Severity of Cough in Patients Undergoing Abdominal Surgery: A Prospective, Randomized, Double-Blind Study
Jin-Chun Shen,Jian-Guo Xu,Zhi-Qiang Zhou,Hong-Jun Liu,Jian-Jun Yang
DOI: https://doi.org/10.1016/j.curtheres.2008.12.002
2008-01-01
Current Therapeutic Research
Abstract:BACKGROUND: Fentanyl congeners have been found to induce cough during Induction of general anesthesia. Studies of fentanyl and sufentanil have found incidence rates of 28% to 65176 and 15%, respectively. However no study has assessed the occurrence of cough Induced by remifentanil.OBJECTIVE: The aim of this study was to assess the effect of equivalent (loses Of fentanyl, sufentanil, and remifentanil on cough.METHODS: Patients rated American Society of Anesthesiologists class I or II of either sex, aged IS to 60 years, who were scheduled for elective abdominal surgery with general anesthesia were randomly and equally assigned to 3 groups using a computer-generated table of random numbers. The patients received equivalent doses of fentanyl 2 mu g/kg, sufentanil 0.2 mu g/kg, or remifentanil 2 mu g/kg via IV push. Vital signs (systolic blood pressure [SBP], heart rate [HR], and oxygen saturation via pulse oximetry [SpO(2)]) and the Occurrence and severity of cough were recorded for 2 minutes after drug administration by an anesthesiologist who was blinded to the drug treatment. The severity of cough was graded as none (0), mild ( 1-2), moderate (3-5), or severe (>5).RESULTS: A total of 315 Chinese patients (197 women, 118 men; mean [SDI age, 37.9 [10.4] years) were approached for enrollment and assigned to 3 groups Of 105 patients each; all patients completed the study protocol. The 3 treatment groups were similar in terms of demographic characteristics and type of abdominal Surgery. The incidence of cough was significantly greater in the remifentanil group) (57 [54.3%] patients) than in the fentanyl group (35 [33.3%]; P < 0.01.) or the sufentanil group (32 [30-5%]; P < 0.01). The severity of cough was significantly greater In the remifentanil group (severe, moderate, mild, none: 24, 7, 26, 48) than in the fentanyl (7, 9, 19, 70; P < 0.01) or sufentanil group (41, 2, 26, 73; P < 0.01). In all 3 groups, when the patients coughed, significant increases were observed in their SBP (128 [12]-139 [16] mm Hg; P < 0.01) and HR (74 [10]-87 [16] beats/min; P < 0.01). Within 2 minutes after drug administration, 62 patients (59%) in the remifentanil group experienced hypoxemia (SpO(2) <90%) necessitating manually assisted mask ventilation, While no patients experienced hypoxemia in the fentanyl or sufentanil group. Three patients (2.9%) in the remifentanil group experienced Muscle rigidity and deterioration of SBP, HR, and SpO(2). No other adverse events were recorded.CONCLUSION: Remifentanil was associated with a significantly greater incidence and severity of cough than equivalent doses of fentanyl or sufentanil. Fentanyl and sufentanil appeared comparable in these Chinese patients undergoing abdominal surgery (Curr Ther Res Clin Exp. 2008 69:480-487) (C) 2008 Excerpta Medica Inc.